231 related articles for article (PubMed ID: 32434431)
1. Cardiovascular disease, heart failure and COVID-19.
Faconti L; Chowienczyk PJ; Shah AM
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926903. PubMed ID: 32434431
[No Abstract] [Full Text] [Related]
2. Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications.
Abassi Z; Assady S; Khoury EE; Heyman SN
Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1080-H1083. PubMed ID: 32223552
[No Abstract] [Full Text] [Related]
3. COVID-19 in patients with cardiovascular diseases.
Hulot JS
Arch Cardiovasc Dis; 2020 Apr; 113(4):225-226. PubMed ID: 32245656
[No Abstract] [Full Text] [Related]
4. COVID-19 and the cardiovascular system.
Zheng YY; Ma YT; Zhang JY; Xie X
Nat Rev Cardiol; 2020 May; 17(5):259-260. PubMed ID: 32139904
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Sommerstein R; Kochen MM; Messerli FH; Gräni C
J Am Heart Assoc; 2020 Apr; 9(7):e016509. PubMed ID: 32233753
[No Abstract] [Full Text] [Related]
6. COVID-19 and Cardiovascular Disease.
Clerkin KJ; Fried JA; Raikhelkar J; Sayer G; Griffin JM; Masoumi A; Jain SS; Burkhoff D; Kumaraiah D; Rabbani L; Schwartz A; Uriel N
Circulation; 2020 May; 141(20):1648-1655. PubMed ID: 32200663
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
Wu L; O'Kane AM; Peng H; Bi Y; Motriuk-Smith D; Ren J
Biochem Pharmacol; 2020 Aug; 178():114114. PubMed ID: 32579957
[TBL] [Abstract][Full Text] [Related]
8. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
Esler M; Esler D
J Hypertens; 2020 May; 38(5):781-782. PubMed ID: 32195824
[No Abstract] [Full Text] [Related]
9. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
mBio; 2020 May; 11(3):. PubMed ID: 32444383
[No Abstract] [Full Text] [Related]
10. COVID-19 and the pulmonary vascular injury.
Dai HL; Guang XF
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972276. PubMed ID: 33176538
[No Abstract] [Full Text] [Related]
11. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Delpino MV; Quarleri J
Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
[No Abstract] [Full Text] [Related]
13. COVID-19 and the Heart.
Strabelli TMV; Uip DE
Arq Bras Cardiol; 2020 Apr; 114(4):598-600. PubMed ID: 32236325
[No Abstract] [Full Text] [Related]
14. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
[No Abstract] [Full Text] [Related]
15. COVID-19 and hypertension.
Kulkarni S; Jenner BL; Wilkinson I
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320927851. PubMed ID: 32431227
[No Abstract] [Full Text] [Related]
16. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.
Gupta MD; Girish MP; Yadav G; Shankar A; Yadav R
Indian Heart J; 2020; 72(1):1-6. PubMed ID: 32423554
[No Abstract] [Full Text] [Related]
17. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
Chen L; Li X; Chen M; Feng Y; Xiong C
Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular implications of SARS-CoV-2 infection: A literature review].
García-Saavedra MB; Rosales-Gutiérrez RR; Valverde E; Chumbes-Aguirre M; Alvarado R; Polo R; Azañero R; Chávez C
Medwave; 2020 Aug; 20(7):e8008. PubMed ID: 32877391
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 challenging cell biology.
Bullerdiek J
Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
[No Abstract] [Full Text] [Related]
20. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
